Aberdeen Asia Focus PLC (AAS) — Investment Research Note

Executive summary

AAS is a London-listed closed-end investment trust (FTSE 250, managed by abrdn/Aberdeen Group) that holds a 50–60-name portfolio of under-researched Asian ex-Japan smaller companies, with current emphasis on Taiwan/Korea AI-supply-chain names and Southeast Asian defensives 2026-03-30 half-year. Over the period covered, NAV total return has accelerated — H1 FY24 –0.7%, FY25 +20.3%, H1 FY26 +11.4% — driven by stock-picking in AI-adjacent small caps (Chroma ATE, Taiwan Union, Hansol Chemical, Leeno, Hyundai Electric, MPI, SAS, ASMPT) and a narrowing of the discount from 14–16% to 8.9% 2026-03-30 half-year. The single most important point for valuation today is that the shares trade at or very near NAV — the historic discount cushion has largely been monetised, so forward returns depend almost entirely on underlying portfolio performance.

Fair value estimate

• Methodology: NAV-based (as appropriate for a closed-end fund) plus a fair discount band.
• Anchor: NAV/share of 421.7p at 31 Jan 2026 2026-03-30 half-year. Rolling the Asian small-cap tape (MSCI AC Asia ex Japan Small Cap and the manager's narrative of continued AI-driven gains) forward ~8 months to Oct 2026 implies an estimated current NAV in the ~460–490p range (12% H1 run-rate; buybacks have added a further ~1–2p of per-share NAV accretion).
• Fair discount: 0–10% for a strong-track-record, FTSE 250, actively bought-back trust. Over the period covered the discount has ranged from 8.9% to ~16%.
• Fair value per share: 420p–480p (central 450p).
• Implied market cap (at ~134.4m shares outstanding): £565m–£645m, central ~£605m.
• vs. current £631.6m market cap and 467p share price: shares are essentially fair, with mid-case –3.6% downside and a range of roughly –10% to +3%.

Sector context

• Classification confirmed: Financial Services (ICB), specifically an equity investment trust.
• Quality vs. peers: above-average — 30-year track record (NAV total return +3,365.8% / 12.4% p.a. since 1995 vs. benchmark 5.3% p.a.), 0.89% ongoing charge, 7.6% net gearing, FTSE 250 status, and an active abrdn Asia team of ~15 analysts. Governance has been proactive (progressive dividend, 5-year conditional tender, step-up in buybacks) 2026-03-30 half-year.
• Listed peers: Scottish Oriental Smaller Companies (SST), Pacific Assets Trust (PAC), abrdn Asian Income Fund (AAIF) are the closest; the large-cap Asian equivalents are Pacific Horizon (PHI) and Schroder AsiaPacific (SDP).

Investment thesis (3 bullets)

1. Meaningful AI-supply-chain exposure delivered via Asian small-cap specialists you cannot easily replicate passively. AI-linked holdings now span Taiwan Union (CCL for AI PCBs), Chroma ATE (power/semi testing), Accton (hyperscaler networking switches), ASMPT (advanced packaging), SAS/GlobalWafers (silicon wafers), MPI (probe cards), Leeno (test pins/sockets), Hansol Chemical (semi materials) and Hyundai Electric (data-centre transformers) — collectively ~25–30% of total assets 2026-03-30 half-year.
2. Demonstrable alpha and governance discipline. NAV TR of +11.4% in H1 FY26 beat the benchmark +9.0% by ~100bps; FY25 was +20.3% vs. +7.6%; 50.8% vs. 37.2% ahead since the Aug 2021 tender gate 2026-03-30 half-year. Board has stepped up buybacks (5.8m shares in H1 FY26 at a 3.9% of share-count rate, additional 805k post-period) 2026-03-30 half-year.
3. Discount compression and FTSE 250 inclusion have improved durability of the rating. Discount narrowed from 13.1% (Jan 2025) to 8.9% (Jan 2026); retail holder share rose from 26.8% to 30.0% 2026-03-30 half-year. This reduces (though does not eliminate) the risk that outperformance leaks into discount widening.

Key risks (3 bullets)

1. Discount is now narrow — valuation cushion has been used up. With shares trading at or above the ~5–10% band seen for strong peers, forward returns are a pure function of underlying NAV, i.e. of Asian small-cap performance. Any sector-wide risk-off would likely widen the discount AND hit NAV simultaneously 2026-03-30 half-year.
2. Concentrated AI-cycle risk precisely as the manager has flagged. The report explicitly warns of "increasing reliance of markets on the AI narrative and… rising earnings expectations for companies in the associated supply chain" and the team has been actively taking profits, implying their own view is that this cohort is stretched 2026-03-30 half-year.
3. Geopolitical / Taiwan concentration risk. Taiwan is the second-largest country weighting with multiple semi-ecosystem names (Taiwan Union, Chroma, Accton, SAS, MPI, AVC, Makalot). A Taiwan Strait event or escalation of US semi export controls would be portfolio-wide, not idiosyncratic 2026-03-30 half-year.

Operating leverage

Operating leverage at the fund level is modest and tightly bounded. The ongoing cost base is a tiered management fee (0.85% to £250m / 0.60% to £750m / 0.50% above) plus ~£0.4m of administration + promotion, giving a 0.89% ongoing charge ratio 2026-03-30 half-year. Because the management fee is market-cap-based (not NAV-based), the fee scales with the share price rather than compressing in an AI boom — so upside NAV surprise flows through almost 1:1 to NAV TR, but there is no multi-bagging of fund-level profit from a revenue beat. The real operating leverage is embedded in the underlying holdings — Chroma, Taiwan Union, Accton, Hansol, Leeno are the kinds of fixed-R&D-heavy semi/materials businesses where a 10–20% revenue beat can lift operating profit 30–60% — but a holder of AAS captures that only at the ~2–3% portfolio-weight level per name, significantly diluted by the ~70% of the portfolio in financials, consumer, real estate, pharma and plantations. Net: this is a moderate operating-leverage vehicle, not a geared bet on AI capex.

Value-trap signals

None identified. Dividend has grown for 30 years (joining AIC "Next Generation Dividend Heroes"), balance sheet carries ~£55m of debt vs. £593m shareholders' funds (comfortable covenants, 7.6% net gearing), going-concern basis affirmed, no related-party controversy, no restatements, and 95%+ of portfolio is Level 1 quoted equity.

Earnings vs. expectations

Investment trusts do not report EPS guidance in the way operating companies do, so the relevant yardstick is NAV TR vs. (a) the MSCI AC Asia ex Japan Small Cap benchmark and (b) the Board's stated dividend target. The pattern across the filings is clear: FY23 +3.0% vs. +3.8% (narrow miss), H1 FY24 –0.7% vs. +4.5% (miss, driven by India sell-off and Taiwan underweight), H1 FY25 +7.1% vs. –1.9% (large beat), FY25 +20.3% vs. +7.6% (large beat), H1 FY26 +11.4% vs. +9.0% (modest beat) 2023-03-31, 2024-03-28, 2025-03-31, 2026-03-30 half-year. Dividend targets of 6.41p (FY24) → 6.42p (FY25) → ≥6.43p (FY26) have been met or raised each year. Pattern: steady beats since mid-2024 after the manager leaned harder into Taiwan/Korea AI supply-chain.

Conviction

4 / 5 — high.

Anchors: NAV is a hard, audited, mark-to-market Level-1 figure; the valuation methodology (NAV ± discount) is unambiguous for a closed-end fund; 30-year track record and consistent governance give confidence in rolling the NAV forward; the current discount sits within a well-populated historical range.

Caveats: the exact current NAV between reporting dates is modelled rather than disclosed (reported NAV lag of ~8 months), and the "fair discount" is a judgment call that could reasonably be anywhere from 0% to 10% depending on sector sentiment.